Recombinant Bacillus licheniformis Phosphoribosylformylglycinamidine cyclo-ligase (PurM) is an enzyme that plays a crucial role in purine biosynthesis . Specifically, it catalyzes the ATP-dependent cyclization of formylglycinamide ribonucleotide (FGAR) to 5'-phosphoribosyl-5-aminoimidazole (AIR), a critical step in the de novo purine biosynthetic pathway . PurM belongs to the PurM superfamily, which includes other ATP-utilizing enzymes such as PurL, selenophosphate synthetase (SelD), iron-nickel hydrogenase maturation protein (HypE), and thiamine phosphate kinase (ThiL) .
PurM functions as a key enzyme in the purine de novo biosynthesis pathway. The reaction it catalyzes is essential for creating the imidazole ring, a fundamental component of purine nucleotides like adenine and guanine . The PurM superfamily is characterized by a poorly understood ATP-binding motif with a signature sequence, DX$$ _4 $$GAXP .
In Escherichia coli and Salmonella typhimurium, the genes involved in the early steps of purine biosynthesis have been mapped and studied . The historical misinterpretations of gene-enzyme relationships have been corrected, with purM now correctly assigned in E. coli .
| Enzyme | Reaction | Gene |
|---|---|---|
| Amidophosphoribosyltransferase (EC 2.4.2.14) | Phosphoribosylpyrophosphate → Phosphoribosylamine | purF |
| GAR synthetase (EC 6.3.4.13) | Phosphoribosylamine → GAR | purD |
| FGAM synthetase (EC 6.3.5.3) | FGAR → FGAM | purG |
| Phosphoribosylaminoimidazole synthetase (EC 6.3.3.1) | FGAM → Phosphoribosylaminoimidazole | purL |
Note: purG in E. coli is now designated as purM .
PurM is not only vital for purine synthesis but also indirectly influences microbial metabolism . Purines are essential for DNA and RNA synthesis, energy transfer (ATP, GTP), and signaling molecules. Disruptions in purine metabolism can affect cell growth, differentiation, and virulence .
Given its role in fundamental metabolic processes, PurM can be a target for developing antimicrobial agents . Inhibiting PurM can disrupt purine synthesis, affecting bacterial growth and survival. Some studies focus on metabolites from microorganisms like Bacillus licheniformis for their antimicrobial properties, suggesting that targeting enzymes like PurM could be a viable strategy .
KEGG: bld:BLi00701
STRING: 279010.BL01484
Phosphoribosylformylglycinamidine cyclo-ligase (purM) is an essential enzyme in the purine biosynthesis pathway that catalyzes the ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) to formylglycinamidine ribonucleotide (FGAM). In B. licheniformis, this enzyme contributes to the de novo purine biosynthesis pathway, which is critical for nucleotide formation and subsequent DNA and RNA synthesis. The enzyme functions as part of a multi-step pathway that ultimately leads to inosine monophosphate (IMP), a precursor for both adenine and guanine nucleotides.
To study purM function in B. licheniformis, researchers typically employ gene deletion or overexpression methodologies similar to those used for other genes in this organism. For deletion studies, temperature-sensitive plasmids with kanamycin resistance markers can be used, with upstream and downstream fragments amplified using specific primers, followed by SOE-PCR fusion and transformation into B. licheniformis . Growth curve analyses in the presence and absence of the gene provide insights into its physiological relevance.
For effective recombinant expression of B. licheniformis purM, several expression systems have demonstrated success, with the choice depending on research objectives:
E. coli-based expression systems:
BL21(DE3) with pET vector systems offer high protein yields under IPTG induction
T7 promoter-based systems typically provide strong expression control
Addition of an N-terminal His-tag facilitates purification via nickel affinity chromatography
Bacillus-based expression systems:
B. subtilis is often preferred due to its genetic similarity to B. licheniformis
Strong constitutive promoters like P43UTR12 can be used to replace the native promoter of purM for overexpression
Temperature-sensitive plasmids facilitate genomic integration, as demonstrated for other B. licheniformis genes
When implementing these systems, cultivation conditions should be optimized (37°C, 220 rpm) and protein expression verified through SDS-PAGE and Western blotting. For B. licheniformis-based expression, electroporation-based transformation methods have shown success for other recombinant proteins in this organism .
Multiple complementary approaches can be employed to measure purM activity in recombinant B. licheniformis strains:
Spectrophotometric enzyme assays:
Direct measurement of ADP formation using a coupled enzyme system (pyruvate kinase/lactate dehydrogenase) that monitors NADH oxidation at 340 nm
Quantification of inorganic phosphate released during ATP hydrolysis using malachite green assay
Growth-based functional assessment:
Complementation studies using purM-deficient strains on minimal media
Growth curve analysis under standard conditions (37°C, 230 rpm) comparing recombinant versus wild-type strains
Survival rate assessment following oxidative stress (similar to methods used in H₂O₂-kill assays for other B. licheniformis proteins)
Table 1. Recommended conditions for purM activity measurement in B. licheniformis:
| Parameter | Optimal Condition | Notes |
|---|---|---|
| pH | 7.5-8.0 | Activity significantly reduced below pH 7.0 |
| Temperature | 37°C | Matches optimal growth temperature |
| Buffer | 50 mM Tris-HCl | With 5 mM MgCl₂ and 1 mM DTT |
| Substrate (FGAR) | 0.1-1.0 mM | Commercially available or synthesized |
| ATP | 2-5 mM | Required as co-substrate |
| Incubation time | 15-30 min | Longer periods may show substrate limitation |
Growth curves should be generated with OD₆₀₀ measurements taken hourly for at least 12 hours to properly assess the impact of purM expression on bacterial physiology .
Oxidative stress significantly influences purM expression and function in B. licheniformis through several mechanisms:
Transcriptional regulation:
Research indicates that oxidative stress-responsive transcription factors may regulate purM expression in B. licheniformis, similar to how YvmB regulates other genes under oxidative conditions . Under H₂O₂ exposure (2 mM), B. licheniformis demonstrates altered gene expression patterns to cope with oxidative damage . While specific purM regulation hasn't been directly documented, the enzyme likely experiences similar regulatory control as other biosynthetic pathways during stress.
Protein modification and stability:
Oxidative stress can induce post-translational modifications of purM through:
Oxidation of cysteine residues, potentially forming disulfide bonds (similar to YvmB C57 oxidation)
Carbonylation of susceptible amino acids affecting catalytic function
Altered protein half-life due to increased proteolysis of damaged proteins
Metabolic impact:
H₂O₂ challenge assays reveal that B. licheniformis adjusts metabolic pathways during oxidative stress . purM function may be diverted from growth-related nucleotide synthesis toward stress-response pathways, as evidenced by survival rate measurements in stress conditions for other B. licheniformis strains .
To investigate these effects experimentally, researchers should employ H₂O₂-kill assays (2 mM H₂O₂, 15 min exposure) followed by CFU counting to determine survival rates , combined with RT-qPCR to measure purM expression changes.
Enhancing thermostability of recombinant B. licheniformis purM can be achieved through strategic structural modifications based on both computational prediction and experimental validation:
Computational design approaches:
Homology modeling based on known purM structures from thermophilic Bacillus species
Molecular dynamics simulations at elevated temperatures (45-60°C) to identify flexible regions
Identification of destabilizing surface residues for targeted substitution
Experimental stabilization strategies:
Site-directed mutagenesis:
Introduction of additional salt bridges at surface-exposed regions
Proline substitutions in loop regions to reduce conformational flexibility
Conversion of free cysteines to serines to prevent oxidation-related instability
Directed evolution:
Error-prone PCR to generate variant libraries
Screening under thermal challenge conditions
Iterative selection of improved variants
Table 2. Potential thermostabilizing mutations based on comparative analysis with thermophilic homologs:
| Region | Target Residue | Suggested Mutation | Rationale |
|---|---|---|---|
| Active site periphery | Lys→Arg | Enhanced salt bridge formation | |
| Loop regions | Gly→Ala/Pro | Reduced conformational entropy | |
| Surface-exposed areas | Asn/Gln→Asp/Glu | Increased ionic interactions | |
| β-strand edges | Hydrophilic→Hydrophobic | Enhanced core packing |
Validation should be performed through differential scanning calorimetry and residual activity measurements after thermal challenge (similar to the 45°C incubation methods used for other B. licheniformis proteins) .
The choice of promoter significantly influences both the expression level and functionality of recombinant purM in B. licheniformis:
Constitutive promoter systems:
The P43UTR12 promoter from B. subtilis has demonstrated strong expression capability in B. licheniformis for various genes . When applied to purM expression, this promoter provides:
Inducible promoter systems:
IPTG-inducible systems: Allow titratable expression but may suffer from leakiness
Xylose-inducible systems: Provide tighter regulation with lower background
Temperature-sensitive systems: Enable expression control through cultivation temperature shifts
Growth phase-dependent promoters:
Promoters active during specific growth phases can align purM expression with cellular needs:
Stationary phase promoters minimize metabolic burden during active growth
Exponential phase promoters maximize expression when resources are abundant
Table 3. Comparative analysis of promoter systems for purM expression in B. licheniformis:
| Promoter System | Expression Level | Advantages | Limitations | Application Scenario |
|---|---|---|---|---|
| P43UTR12 | High, constitutive | Consistent expression, no inducer required | Metabolic burden | Biochemical characterization |
| Pspac (IPTG) | Medium, inducible | Controllable expression | Leaky expression, IPTG cost | Expression optimization studies |
| PxylA (xylose) | Medium, tightly regulated | Low background | Requires xylose supplementation | Protein toxicity studies |
| Stress-responsive | Variable, condition-dependent | Aligned with physiological state | Unpredictable expression levels | In vivo functional studies |
Implementation methods for promoter replacement follow established protocols including amplification of the promoter region, SOE-PCR fusion with flanking regions, and integration into the B. licheniformis genome using temperature-sensitive vectors, as demonstrated for other genes .
Optimizing solubility of recombinant B. licheniformis purM requires a multi-faceted approach addressing protein folding, expression conditions, and potential fusion partners:
Expression condition optimization:
Temperature reduction: Lowering culture temperature to 25-30°C after induction significantly improves proper folding
Induction optimization: Using lower inducer concentrations and extended expression periods
Media supplementation: Addition of 1-5% glycerol or 0.5-1% glucose to reduce metabolic burden
Growth rate control: Maintaining slower growth rates through defined media formulations
Molecular engineering strategies:
Fusion partners to enhance solubility:
Thioredoxin (Trx) - maintains reducing environment
Maltose-binding protein (MBP) - provides strong solubilizing effect
SUMO tag - improves folding and can be precisely removed
Codon optimization:
Harmonization rather than maximization of codon usage
Adjustment of rare codons to match translational pausing of native host
Molecular chaperone co-expression:
GroEL/GroES system for folding assistance
DnaK/DnaJ/GrpE for preventing aggregation
ClpB for disaggregation of protein clusters
Table 4. Solubility enhancement strategies ranked by effectiveness for B. licheniformis recombinant proteins:
| Strategy | Relative Effectiveness | Implementation Complexity | Notes |
|---|---|---|---|
| Temperature reduction (25°C) | ++++ | + | Primary approach, minimal modifications needed |
| MBP fusion | ++++ | ++ | Requires fusion construct design, TEV cleavage site |
| GroEL/ES co-expression | +++ | +++ | Requires additional plasmid, selection system |
| Medium supplementation | ++ | + | Easily implemented, modest improvements |
| SUMO fusion | +++ | +++ | Provides native N-terminus after cleavage |
| Codon harmonization | +++ | ++ | Requires bioinformatic analysis, gene synthesis |
Implementation methods should follow established B. licheniformis transformation protocols using electroporation and appropriate selection markers , with solubility assessed through comparative analysis of soluble versus insoluble fractions via SDS-PAGE.
Research on recombinant B. licheniformis purM faces several important limitations while offering promising future directions:
Current limitations:
Regulatory complexity:
The intricate regulation of purine biosynthesis in B. licheniformis remains incompletely characterized, especially under various stress conditions. While oxidative stress response mechanisms have been studied for other proteins like YvmB , specific regulatory elements controlling purM expression require further investigation.
Structural knowledge gaps:
Limited availability of crystal structures for B. licheniformis purM hampers rational engineering efforts. Most structural predictions rely on homology modeling based on related bacterial species.
Metabolic integration challenges:
The full impact of purM overexpression on cellular metabolism, particularly under stress conditions, remains unclear. Studies similar to the H₂O₂ challenge assays used for other B. licheniformis proteins could provide valuable insights.
Future research directions:
Systems biology approach:
Integrating transcriptomics, proteomics, and metabolomics to understand how recombinant purM expression affects the entire purine biosynthesis pathway and connected metabolic networks.
Stress-responsive expression systems:
Development of promoter systems that modulate purM expression in response to specific environmental signals, building upon knowledge of oxidative stress response in B. licheniformis .
Biotechnological applications:
Exploring the potential of engineered purM variants for enhanced nucleotide production, leveraging B. licheniformis' established role in biotechnology .
Comparative genomics:
Systematic comparison of purM across different Bacillus species to identify evolutionary adaptations that could inform protein engineering strategies.
Table 5. Priority research areas for advancing recombinant B. licheniformis purM understanding:
| Research Area | Expected Impact | Technological Approach | Timeline |
|---|---|---|---|
| Regulatory network mapping | High | ChIP-seq, RNA-seq, protein-DNA interaction studies | Short-term |
| Structural determination | High | X-ray crystallography, cryo-EM | Medium-term |
| Metabolic flux analysis | Medium | ¹³C metabolic flux analysis, metabolomics | Short to medium-term |
| Protein engineering | High | Directed evolution, rational design | Medium to long-term |
| Stress response integration | Medium | Transcriptomics under varied stress conditions | Short-term |
The integration of these research directions will provide comprehensive understanding of purM's role in B. licheniformis and maximize its biotechnological potential.
Working with recombinant B. licheniformis purM necessitates careful attention to ethical considerations and biosafety protocols:
Biosafety considerations:
B. licheniformis is generally classified as a Biosafety Level 1 (BSL-1) organism, but introduction of recombinant purM requires additional precautions:
Containment measures:
Standard BSL-1 practices including handwashing, no eating/drinking in laboratory
Use of biological safety cabinets for aerosol-generating procedures
Proper decontamination of work surfaces and equipment
Genetic stability monitoring:
Strain-specific biosafety:
Some strains of B. licheniformis have been reported to carry antibiotic resistance genes, necessitating careful selection of laboratory strains . Before using B. licheniformis for recombinant protein expression, verification of absence of virulence factors and antibiotic resistance genes is essential .
Ethical considerations:
Environmental impact assessment:
Evaluation of potential ecological consequences if recombinant strains were released
Implementation of biological containment strategies (kill switches, auxotrophic markers)
Proper waste management protocols specific to recombinant organisms
Dual-use research awareness:
Assessment of potential for misuse of research findings
Appropriate levels of information disclosure in publications
Compliance with institutional biosecurity policies
Transparent reporting:
Complete disclosure of methodologies in publications
Sharing of strains and constructs with qualified researchers
Deposition of sequence data in public repositories
Table 6. Recommended biosafety protocols for recombinant B. licheniformis purM work:
| Protocol Element | Specific Measures | Implementation Timeline |
|---|---|---|
| Risk assessment | Document potential hazards, exposure routes, and mitigation strategies | Before project initiation |
| Training | Lab-specific procedures for recombinant B. licheniformis handling | Prior to handling organisms |
| Containment | Physical barriers, work practices, and decontamination procedures | Throughout experimental work |
| Monitoring | Regular verification of strain characteristics and containment integrity | Weekly/monthly during project |
| Waste management | Autoclave all materials containing recombinant organisms | After each experimental session |
| Emergency response | Documented procedures for spills or accidental exposures | Before project initiation, with regular drills |